Atlas Trials

ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer

Clinical trial NCT07444541 · RECRUITING

Trial details

NCT number
NCT07444541
Sponsor
Anova Innovation Limited
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2026-08-01
Primary completion
2027-08-01
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.